CHIAPPELLA, Annalisa
 Distribuzione geografica
Continente #
NA - Nord America 502
EU - Europa 288
AS - Asia 254
SA - Sud America 5
AF - Africa 3
OC - Oceania 1
Totale 1053
Nazione #
US - Stati Uniti d'America 483
CN - Cina 191
IT - Italia 100
IE - Irlanda 42
SE - Svezia 33
JP - Giappone 22
CA - Canada 19
FR - Francia 19
GB - Regno Unito 17
IN - India 13
AT - Austria 10
DE - Germania 10
CH - Svizzera 9
KR - Corea 8
UA - Ucraina 8
ES - Italia 7
RU - Federazione Russa 6
VN - Vietnam 6
GR - Grecia 4
HU - Ungheria 4
NL - Olanda 4
PL - Polonia 4
FI - Finlandia 3
IR - Iran 3
PK - Pakistan 3
SN - Senegal 3
TR - Turchia 3
BE - Belgio 2
BR - Brasile 2
CL - Cile 2
DK - Danimarca 2
TW - Taiwan 2
AU - Australia 1
HK - Hong Kong 1
HR - Croazia 1
IL - Israele 1
NO - Norvegia 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
UY - Uruguay 1
Totale 1053
Città #
Chandler 104
Beijing 51
Dublin 42
Torino 41
Fairfield 35
Houston 29
Redwood City 27
Shanghai 20
Duncan 19
Wilmington 19
Nyköping 17
Ashburn 16
Dearborn 16
Medford 16
Woodbridge 14
Guangzhou 13
Princeton 13
Ann Arbor 12
Seattle 10
Vienna 10
Cambridge 9
Hebei 9
Mississauga 9
Chengdu 8
Tokyo 8
Villeurbanne 8
Guiyang 7
Boston 6
Jinan 6
Nanjing 6
Pisa 6
Changsha 5
Fremont 4
Hefei 4
Munich 4
Norwalk 4
Paris 4
Seoul 4
Warsaw 4
Xian 4
Boves 3
Columbus 3
Fuzhou 3
Geneva 3
Hangzhou 3
New York 3
Portland 3
Somerset 3
Zhengzhou 3
Bath 2
Bengaluru 2
Buffalo 2
Chennai 2
Chicago 2
Delhi 2
Des Moines 2
Dong Ket 2
Durham 2
Harbin 2
Jacksonville 2
Kish 2
Lausanne 2
Madrid 2
Moscow 2
Ottawa 2
Raritan 2
Rochester 2
San Diego 2
San Francisco 2
San Mateo 2
Surrey 2
Taipei 2
Talca 2
Tianjin 2
Toronto 2
Verona 2
Woodbury 2
Wuhan 2
Zurich 2
Ans 1
Ascoli Piceno 1
Barcelona 1
Bethesda 1
Bologna 1
Brussels 1
Bucharest 1
Budapest 1
Casperia 1
Central District 1
Changchun 1
Cheboksary 1
Chongqing 1
Cincinnati 1
Collegeville 1
Copenhagen 1
Debrecen 1
Duarte 1
Falls Church 1
Greenock 1
Guangdong 1
Totale 751
Nome #
ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma 393
Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials 127
Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma 108
Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi 84
Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue 56
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death 55
Epigenomic evolution in diffuse large B-cell lymphomas 53
Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi 53
Prognostic role of pre-radiation therapy 18F-fluorodeoxyglucose positron emission tomography for primary mediastinal B-cell lymphomas treated with R-CHOP or R-CHOP-like chemotherapy plus radiation 50
Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation in mantle cell lymphoma: results of a Fondazione Italiana Linfomi (FIL) multicentre, randomised, phase 3 trial 31
Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study 30
Khorana score and histotype predicts incidence of early venous thromboembolism in Non-Hodgkin lymphomas: A Pooled-Data analysis of 12 clinical trials of fondazione italiana linfomi (FIL) 29
Allogeneic stem cell transplantation in mantle cell lymphoma in the era of new drugs and CAR-T cell therapy 28
Totale 1097
Categoria #
all - tutte 1784
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1784


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201830 0000 00 03 20610
2018/201944 1001 24 314 06121
2019/2020132 5049 319 1514 2118186
2020/2021114 981221 56 63 1011419
2021/2022533 13434958 5438 4846 41306449
2022/2023220 23351236 1369 320 0000
Totale 1097